Prolongation of biologic dosing intervals in patients with stable psoriasis:  a feasibility study

2017-08-01

Therapeutic Drug Monitoring , Volume 39 - Issue 4 p. 379- 386

Additional Metadata
Persistent URL	doi.org/10.1097/FTD.0000000000000420, hdl.handle.net/1765/100344
Journal	Therapeutic Drug Monitoring
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Bezooijen, J., van Doorn, M., Schreurs, M., Koch, B., Velthuis, H.T. (Henk Te), Prens, E., & van Gelder, T. (2017). Prolongation of biologic dosing intervals in patients with stable psoriasis: a feasibility study. Therapeutic Drug Monitoring, 39(4), 379–386. doi:10.1097/FTD.0000000000000420

Publication